T0	Participants 13 37	gastrointestinal cancer:
T1	Participants 42 99	Southeastern Cancer Study Group experience, 1979 to 1983.
T2	Participants 118 141	gastrointestinal cancer
T3	Participants 197 288	from 1979 to 1983 at 30 member institutions of the Southeastern Cancer Study Group (SECSG).
T4	Participants 398 413	1,087 patients.
T5	Participants 881 889	America.